NCT04569227View on ClinicalTrials.gov

Prevention of COVID-19 Infection to Severe Pneumonia or ARDS

PHASE2UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2021

Primary Completion Date

September 30, 2021

Study Completion Date

November 30, 2021

Conditions
Covid19 Pneumonia
Interventions
DRUG

EC-18

2000 mg PO daily

DRUG

Placebo

PO daily

Trial Locations (2)

10451

RECRUITING

Lincoln Medical Center, The Bronx

02886

RECRUITING

Kent County Memorial Hospital, Warwick

Sponsors
All Listed Sponsors
lead

Enzychem Lifesciences Corporation

INDUSTRY